References in periodicals archive ?
About 5%-10% of upper respiratory tract infections in children develop into acute bacterial sinusitis, according to the new guidelines, published in Pediatrics.
Acute Bacterial Sinusitis. New England Journal of Medicine, 2004; 351: 902-910.
Acute bacterial sinusitis is mostly preceded by viral upper respiratory infections.
Evidence suggests that a short duration of treatment is as effective as a longer course of treatment for certain common community-acquired infections, such as acute otitis media, acute bacterial sinusitis, infectious exacerbations of chronic bronchitis, community-acquired pneumonia, and acute pyelonephritis.
introduction in 1996, LEVAQUIN has gained widespread use in the treatment of adults for a variety of bacterial infections caused by specific pathogens, including: acute bacterial sinusitis, acute bacterial exacerbation of chronic bronchitis, nosocomial pneumonia, community-acquired pneumonia, complicated and uncomplicated skin and skin structure infections (mild to moderate), chronic bacterial prostatitis, complicated and uncomplicated urinary tract infections (mild to moderate) and acute pyelonephritis (mild to moderate).
The FDA said the changes include the removal of two of the three previously approved indications - acute bacterial sinusitis and acute bacterial exacerbations of chronic bronchitis - from the drug's label.
Community-acquired respiratory tract infections (RTIs), including acute bacterial sinusitis, acute otitis media, acute exacerbations of chronic bronchitis, and community-acquired pneumonia, are among the most frequent infections treated by physicians and represent a major international health problem (1).
Acute bacterial sinusitis is usually preceded by a viral infection of the upper respiratory tract.
The gold standard for the diagnosis of acute bacterial sinusitis is the recovery of bacteria in high density (at least 10,000 colony-forming units/mL) from the cavity of a paranasal sinus.
Avelox(R) has been specifically approved for community- acquired pneumonia, acute bacterial exacerbation of chronic bronchitis and acute bacterial sinusitis. Avelox(R) will be available in Canadian pharmacies this week, in time to combat RTI season over the coming winter months.
Full browser ?